CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
April 10th 2019
A young advocate emphasizes the importance of communication between parents and their children about an ovarian cancer diagnosis.
April 8th 2019
A gynecologic-oncology clinical nurse specialist and one of this year’s CURE Ovarian Cancer Heroes discussed the lack of resources for patients with ovarian cancer and the need for more research.
April 4th 2019
We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.
April 3rd 2019
Patients speak up on the rarely discussed side effects of gynecologic cancers.
April 1st 2019
Women with this disease are living longer, despite common recurrence.
March 31st 2019
An endometrial cancer survivor runs to raise awareness for a disease many don’t want to talk about.
March 30th 2019
Cancer isn’t black and white, nor is it predictable. A diagnosis and the subsequent treatment of the many varieties of this complex disease can be challenging because of gray areas and uncertainties.
March 29th 2019
The “Whiskey Cavalier” actor opens up about caregiving for his mother following her ovarian cancer diagnosis.
March 28th 2019
This week, we spoke with all three of CURE’s 2019 Ovarian Cancer Heroes: Ryan Mitstifer Walton, Paula Anastasia, RN, MN, AOCN, and Shannon Westin, M.D., M.P.H.
March 26th 2019
Researchers define the genetic characteristics of ovarian tumors-- information that could lead to new opportunities for personalized therapy and may explain why screening programs for the disease haven’t been successful.
March 24th 2019
Ten years later, a woman with a BRCA1 mutation finally feels more like herself.
March 22nd 2019
Understand how the rare relative of ovarian cancer is diagnosed and treated.
March 21st 2019
Did we bring this scary, painful, financially draining monster into our lives by eating too many cookies and not doing enough jumping jacks? We need a reliable diagnostic screening tool for ovarian cancer and we need it now.
March 21st 2019
In this week’s episode, we spoke with the most decorated Olympic gymnast and ovarian cancer survivor Shannon Miller before CURE’s second annual Ovarian Cancer Heroes gala.
March 20th 2019
Lenvima (lenvatinib) in combination with weekly paclitaxel induced activity among those with recurrent endometrial and platinum-resistant epithelial ovarian cancer, according to results from a phase I study.
March 19th 2019
Treatment with the combination of Keytruda (pembrolizumab), Avastin (bevacizumab) and metronomic cyclophosphamide appeared safe and effective in women with recurrent epithelial ovarian cancer, according to results from an open-label phase 2 study.
March 18th 2019
Prior exposure to PARP inhibitor treatment may not lead to resistance in future use with these agents in women with recurrent epithelial ovarian cancer, meaning repeat use could become more common.
March 18th 2019
Side effects decreased among patients with high-risk ovarian cancer who received an individualized starting dose of Zejula (niraparib), based upon baseline bodyweight and platelet counts, compared with a fixed starting dose.
March 17th 2019
Patients with recurrent ovarian cancer who received Zejula (niraparib) maintenance therapy experienced longer progression-free survival, as well as more time without symptoms or toxicity compared with placebo, according to results from the phase 3 ENGOT-OV16/NOVA trial.
March 16th 2019
The importance of teamwork between patients and their caregivers was a common theme at the second annual Ovarian Cancer Heroes event held in Honolulu, Hawaii.
February 28th 2019
In this week’s episode, we spoke with actor Scott Foley, who opened up about his experience as a caregiver to his mother after her ovarian cancer diagnosis and why he joined the Not on My Watch movement to help educate others.
February 22nd 2019
From shark genomes to celebs and important updates, here is a quick overview of what is making headlines in the cancer space.
February 18th 2019
“Love, Gilda” features never-before-seen diaries, audio and videotapes from the collection of Gilda Radner, who died at age 42 of ovarian cancer.
February 14th 2019
This week, we spoke with FORCE to dispel some of the misconceptions associated with at-home genetic testing for hereditary cancer risk.
February 2nd 2019
Researchers are evaluating the use of folate receptors to treat platinum-resistant ovarian cancer.
January 25th 2019
Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.
January 22nd 2019
There is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. If these promotions have caught your attention and you are considering testing, there is important information that you should know first.
January 18th 2019
The addition of the investigational drug alisertib to a paclitaxel regimen showed promising activity in patients with recurrent ovarian cancer or advanced breast cancer.
January 17th 2019
A recent survey demonstrated the common tradeoffs most patients report regarding treatment decisions, highlighting the importance of shared decision making.